Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

Jump to content

Penem

From Wikipedia, the free encyclopedia

A penem is a type of β-lactam with an unsaturated five-member heterocycle containing a sulfur atom in a pentacyclic ring fused to the β-lactam ring. Penems do not occur naturally; all are synthetic.[1] Related to penems are carbapenems, which have a carbon atom in place of the sulfur atom.[2]

An example is faropenem.[3]

Structure

[edit]
Faropenem, a penem. A sulfur atom and a double bond are present in the pentacyclic ring.[4]
Imipenem, a carbapenem. Imipenem has a sulfur atom that is not in the pentacyclic ring.
Benzylpenicillin, a penicillin. The double bond is absent in the pentacyclic ring.

Penem molecules do not occur naturally, and production of penems is an entirely synthetic process.[5]

Five main penem subgroups thiopenems, oxypenems, aminopenems, alkylpenems, and arylpenems have been produced and are distinguished by the side chain (at position 2) of the unsaturated five-membered ring.[5] One structurally distinct penem is BRL 42715. This molecule has no substitution at the above position, but has a bulky group attached to the β-lactam ring, and it displays effective inhibition of class C β-lactamases, but no antimicrobial activity.[6]

One possible consequence of these structural differences of penems from other β-lactams may be reduced immunogenicity and immunogenic cross-reactivity.[citation needed]

References

[edit]
  1. Richard Wise (1990). "The carbapenems and Penem Antibiotics—a brief review". Antimicrobic Newsletter. 7 (10): 73–78. doi:10.1016/0738-1751(90)90045-E.
  2. "Medscape.com".
  3. Milazzo I, Blandino G, Caccamo F, Musumeci R, Nicoletti G, Speciale A (March 2003). "Faropenem, a new oral penem: antibacterial activity against selected anaerobic and fastidious periodontal isolates". Journal of Antimicrobial Chemotherapy. 51 (3): 721–5. doi:10.1093/jac/dkg120. PMID 12615878.
  4. Schurek, Kristen N.; Wiebe, Ryan; Karlowsky, James A.; Rubinstein, Ethan; Hoban, Daryl J.; Zhanel, George G. (2007). "Faropenem: Review of a new oral penem". Expert Review of Anti-Infective Therapy. 5 (2): 185–198. doi:10.1586/14787210.5.2.185. PMID 17402834.
  5. 1 2 Rusu, Aura; Oancea, Octavia-Laura; Donici, Elena; Uncu, Livia (2025-05-11). "Recent Developments in Penem Antibiotics: Structural and Therapeutic Perspectives". Molecules (Basel, Switzerland). 30 (10): 2126. doi:10.3390/molecules30102126. ISSN 1420-3049. PMC 12113772. PMID 40430299.
  6. Coleman, K.; Griffin, D. R.; Page, J. W.; Upshon, P. A. (September 1989). "In vitro evaluation of BRL 42715, a novel beta-lactamase inhibitor". Antimicrobial Agents and Chemotherapy. 33 (9): 1580–1587. doi:10.1128/AAC.33.9.1580. ISSN 0066-4804. PMC 172706. PMID 2817854.

Further reading

[edit]